Clinical Trials Sponsored by Medivir

Total 175 results

Medivet Pty Ltd

Completed

Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne

Acne Vulgaris

Philippines
Medicis Pharmaceutical Corporation

Completed

A Study to Examine the Effects of Minocycline Extended-Release Tablets on Sperm Production in Human Males.

Human Volunteer

United States
MedicAir Healthcare S.r.l.

Recruiting

Digital App for Telerehabilitation in Respiratory Diseases

Obesity | Bronchiectasis | Chronic Obstructive Pulmonary Disease | Asthma | Respiratory Disease | Long COVID | Lung Fibrosis

Italy
Meditor Pharmaceuticals Ltd.

Withdrawn

Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients

Hypotension | Cardiopulmonary Bypass

United States
Medicis Aesthetics, Inc.

Completed

A Study to Determine How Long Restylane® Will Last After Initial Treatment With 2 Different Re-treatment Schedules.

Rhytids

United States
Mediti Pharma Inc.

Terminated

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Aggression | Dementia | Psychosis | Agitation | Alzheimer Dementia

United States, Canada
MedSIR
AstraZeneca; Experior

Completed

Preoperative Olaparib Endometrial Carcinoma Study (POLEN) (Polen)

Endometrial Carcinoma

Spain
MedSIR
GUARDANT HEALTH

Completed

Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP) (SLLIP)

Lung Cancer

Spain
Medimix Specialty Pharmacy, LLC

Suspended

Efficacy of Novel Drug-combinations for Relief of Psoriasis (ENDURE)

Psoriasis

United States
Medimix Specialty Pharmacy, LLC

Completed

Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study (REVERT)

Menopause

United States
Medicis Global Service Corporation

Completed

Topical Antifungal Treatment for Tinea Cruris

Tinea Cruris

United States, Puerto Rico, Honduras, El Salvador, Belize
Medicis Global Service Corporation

Completed

Topical Antifungal Treatment for Tinea Pedis

Tinea Pedis

United States, Belize
Medicis Global Service Corporation

Completed

Study of Restylane and Perlane in the Correction of Peri-Oral Wrinkles

Peri-oral Wrinkles

United States
Medicis Global Service Corporation

Completed

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

Seborrheic Dermatitis

United States
Medicis Global Service Corporation

Completed

Safety/Efficacy Study of Restylane® in Lip Augmentation

Lip Augmentation

United States
MedSIR
Daiichi Sankyo

Recruiting

HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease (TUXEDO-3)

Metastatic Breast Cancer | Solid Tumor, Adult | Advanced Non-Small Cell Squamous Lung Cancer

Spain, Austria
Associazione Medici Endocrinologi

Unknown

Metformin in Older Adults With Type 2 Diabetes (AMEMET) (AMEMET)

Diabetes Mellitus, Type 2

Italy
Associazione Medici Endocrinologi

Completed

Basal Insulin And Compensation Glycemic In Diabetic Patients In Basal Bolus Outpatient. (BASAL)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1
Medimix Specialty Pharmacy, LLC

Completed

Topical Compounded Pain Creams And Pain Perception (TOPCAPP) (TOPCAPP)

Pain

United States
Medicis Global Service Corporation

Completed

Topical Antifungal Treatment for Tinea Pedis

Tinea Pedis

United States, Puerto Rico
Medicis Global Service Corporation

Unknown

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

Facial Volume

United States
Medicis Global Service Corporation

Completed

Combination Treatment for Moderate to Severe Acne

Acne

United States
MedSIR
Menarini Group

Recruiting

PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin (SABINA)

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer

Spain
MedSIR
Gilead Sciences

Active, not recruiting

Preventive stRategy for IMMU132-relatED AEs in TNBC - PRIMED (PRIMED)

Breast Cancer | Triple Negative Breast Cancer

Spain
Medimix Specialty Pharmacy, LLC

Suspended

Compounded Pain Preparation Absorption Study (ComPASS)

Pain

United States
Medicis Global Service Corporation

Completed

Safety and Efficacy Study to Treat Bacterial Vaginosis

Bacterial Vaginosis

United States
Medicis Global Service Corporation

Unknown

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

Actinic Keratosis

United States
Mediar Therapeutics
ICON plc

Recruiting

A First-in-Human Safety Trial of MTX-463

Healthy

United States
MedSIR
Stemline Therapeutics, Inc.

Not yet recruiting

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. (ADELA)

Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
Hackensack Meridian Health
MedSIR

Recruiting

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy (G360-IIT)

Carcinoma, Non-Small-Cell Lung

United States
MedSIR
Hoffmann-La Roche

Completed

First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC (ATRACTIB)

Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer

Spain, France, United Kingdom, Germany, Italy
MedSIR
MacroGenics; Seagen Inc.

Withdrawn

Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast Cancer (MARGARET)

Advanced Breast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer
Northwestern University
Medicis Pharmaceutical Corporation

Completed

Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone

Forehead/Glabellar Rhytid Complexes

United States
UpTru Inc.
Medicor Research Inc.

Completed

The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples

Urine Sample Authenticity

Canada
MedSIR
Hoffmann-La Roche

Not yet recruiting

PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer (DEMETHER)

HER2-positive Breast Cancer
MedSIR
Cellestia Biotech AG

Terminated

CB-103 Plus NSAI In Luminal Advanced Breast Cancer (CAILA)

Advanced Breast Cancer

Spain
MedSIR
Daiichi Sankyo, Inc.

Not yet recruiting

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases (TUXEDO-4)

Breast Cancer | Metastatic Breast Cancer
MedSIR
Hoffmann-La Roche

Active, not recruiting

Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer (PHERGAIN-2)

Early Breast Cancer

Spain, Italy, Germany, Bulgaria, Hungary
MedSIR
Hoffmann-La Roche

Completed

Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer (PATHFINDER)

Triple Negative Breast Cancer

Spain, Portugal
MedSIR
Daiichi Sankyo, Inc.

Completed

DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease (DEBBRAH)

Advanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal Metastasis

Spain, Portugal
Institut für Pharmakologie und Präventive Medizin

Completed

Pulmonic SAPIEN S3™ THV Registry (PulmonicS3)

Pulmonary Valve Malfunction | Right Ventricular Outflow Tract (RVOT) Dysfunction

Switzerland, Germany, Canada
Institut für Pharmakologie und Präventive Medizin

Completed

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg (Sevicontrol-2)

Hypertension

Germany
Institut für Pharmakologie und Präventive Medizin

Completed

ROUTE Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve (ROUTE)

Aortic Stenosis

Netherlands, France, Austria, Finland, Germany, Italy, Norway, Poland, United Kingdom
Institut für Pharmakologie und Präventive Medizin

Completed

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine (Sevicontrol1)

Hypertension

Germany
Institut für Pharmakologie und Präventive Medizin

Withdrawn

Cardioprotective Effect of RIPC in Patients Undergoing TAVI (CARE-TAVI)

Effectivity of RIPC in Outcomes of TAVI Procedure

Germany
Massachusetts General Hospital
Medicis Pharmaceutical Corporation

Completed

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

Rosacea

United States
Wolfson Medical Center
Meditor Pharmaceuticals Ltd.

Unknown

Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients

End Stage Renal Disease | Hypotension | Intra Dialytic Hypotension

Israel
MedSIR
Medical University of Vienna

Not yet recruiting

REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis (REPOSE)

NSCLC | Brain Metastases | ROS1 Gene Rearrangement
MedSIR
Eli Lilly and Company

Active, not recruiting

ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL (ABIGAIL)

Breast Cancer Metastatic

Italy, Spain, Portugal
Institut für Pharmakologie und Präventive Medizin

Completed

Balloon Expandable Transcatheter Aortic Valve Implantation Without Predilation of the Aortic Valve (EASE-IT)

Aortic Valve Stenosis

Germany

Clinical Trials Sponsored by Medivir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations